top of page


News​


Alpha Tau Announces the Publication of Exceptional Clinical Data from Alpha DaRT, its Novel Alpha Ra
Alpha DaRTâ„¢ achieves a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. Tel Aviv, Israel,...
Nov 26, 2019

Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Manageme
Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...
Apr 11, 2019


Alpha Tau Medical Secures Second Funding Round to Treat Solid Tumors with Alpha Radiation
Following the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors,...
Jul 17, 2017
bottom of page